Eicosapentaenoic acid improves glycemic control in elderly bedridden patients with type 2 diabetes

Tohoku Journal of Experimental Medicine

Volumn 231, Issue 1, 2013, Pages 63-74

  Ogawa, Susumu ^a,b   Abe, Takaaki ^b,c   Nako, Kazuhiro ^a   Okamura, Masashi ^a   Senda, Miho ^a   Sakamoto, Takuya ^a   Ito, Sadayoshi ^a  

^a TOHOKU UNIVERSITY HOSPITAL   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

^c TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Arteriosclerosis; Docosahexaenoic acid; Eicosapentaenoic acid; Fasting plasma glucose; Insulin resistance

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ADIPONECTIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; C PEPTIDE; DOCOSAHEXAENOIC ACID; GLUCOSE; HEMOGLOBIN A1C; ICOSAPENTAENOIC ACID; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

AGED; ARTICLE; BEDRIDDEN PATIENT; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DIABETIC ANGIOPATHY; DIET RESTRICTION; DIET THERAPY; ENTERIC FEEDING; FATTY ACID BLOOD LEVEL; FEMALE; FLUID THERAPY; FOOD COMPOSITION; GERIATRIC PATIENT; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLYCEMIC CONTROL; HUMAN; INFLAMMATION; LIPID METABOLISM; MALE; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PATIENT; POSTPRANDIAL STATE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

AGED; AGED, 80 AND OVER; BED REST; BIOLOGICAL MARKERS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIET; EICOSAPENTAENOIC ACID; FEMALE; HUMANS; HYPERGLYCEMIA; INFLAMMATION; MALE; OXIDATIVE STRESS;

EID: 84885010372     PISSN: 00408727     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.231.63     Document Type: Article

References (37)

1. Calder, P.C. (2012) The role of marine omega-3 (n-3) fatty acids in inflammatory processes, atherosclerosis and plaque stability. Mol. Nutr. Food Res., 56, 1073-1080.
2. Contreras, G.A., Mattmiller, S.A., Raphael, W., Gandy, J.C. & Sordillo, L.M. (2012) Enhanced n-3 phospholipid content reduces inflammatory responses in bovine endothelial cells. J. Dairy Sci., 95, 7137-7150.
3. Cottin, S.C., Sanders, T.A. & Hall, W.L. (2011) The differential effects of EPA and DHA on cardiovascular risk factors. Proc. Nutr. Soc., 70, 215-231.
4. Draper, E., Reynolds, C.M., Canavan, M., Mills, K.H., Loscher, C.E. & Roche, H.M. (2011) Omega-3 fatty acids attenuate dendritic cell function via NF-κB independent of PPARγ. J. Nutr. Biochem., 22, 784-790.
5. Hirasawa, A., Tsumaya, K., Awaji, T., Katsuma, S., Adachi, T., Yamada, M., Sugimoto, Y., Miyazaki, S. & Tsujimoto, G. (2005) Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120. Nat. Med., 11, 90-94.
6. Horrocks, L.A. & Yeo, Y.K. (1999) Health benefits of docosahexaenoic acid (DHA). Pharmacol. Res., 40, 211-225.
7. Ikeya, Y., Fukuyama, N., Kitajima, W., Ogushi, Y. & Mori, H. (2013) Comparison of eicosapentaenoic acid concentrations in plasma between patients with ischemic stroke and control subjects. Nutrition, 29, 127-131.
8. Jinno, Y., Nakakuki, M., Kawano, H., Notsu, T., Mizuguchi, K. & Imada, K. (2011) Eicosapentaenoic acid administration attenuates the pro-inflammatory properties of VLDL by decreasing its susceptibility to lipoprotein lipase in macrophages. Athero- sclerosis, 219, 566-572.
9. Jung, U.J., Torrejon, C., Chang, C.L., Hamai, H., Worgall, T.S. & Deckelbaum, R.J. (2012) Fatty acids regulate endothelial lipase and inflammatory markers in macrophages and in mouse aorta: a role for PPARγ. Arterioscler. Thromb. Vasc. Biol., 32, 2929-2937.
10. Kelley, D.S. & Adkins, Y. (2012) Similarities and differences between the effects of EPA and DHA on markers of atherosclerosis in human subjects. Proc. Nutr. Soc., 71, 322-331.
11. Kelley, D.S., Siegel, D., Vemuri, M., Chung, G.H. & Mackey, B.E. (2008) Docosahexaenoic acid supplementation decreases remnant-like particle-cholesterol and increases the (n-3) index in hypertriglyceridemic men. J. Nutr., 138, 30-35.
12. Kelley, D.S., Siegel, D., Vemuri, M. & Mackey, B.E. (2007) Docosahexaenoic acid supplementation improves fasting and postprandial lipid profiles in hypertriglyceridemic men. Am. J. Clin. Nutr., 86, 324-333.
13. Kim, Y.J., Kim, O.Y., Cho, Y., Chung, J.H., Jung, Y.S., Hwang, G.S. & Shin, M.J. (2012) Plasma phospholipid fatty acid composition in ischemic stroke: importance of docosahexaenoic acid in the risk for intracranial atherosclerotic stenosis. Atherosclerosis, 225, 418-424.
14. Kusunoki, M., Tsutsumi, K., Nakayama, M., Kurokawa, T., Nakamura, T., Ogawa, H., Fukuzawa, Y., Morishita, M., Koide, T. & Miyata, T. (2007) Relationship between serum concentrations of saturated fatty acids and unsaturated fatty acids and the homeostasis model insulin resistance index in Japanese patients with type 2 diabetes mellitus. J. Med. Invest., 54, 243-247.
15. Li, H., Ruan, X.Z., Powis, S.H., Fernando, R., Mon, W.Y., Wheeler, D.C., Moorhead, J.F. & Varghese, Z. (2005) EPA and DHA reduce LPS-induced inflammation responses in HK-2 cells: evidence for a PPAR-gamma-dependent mechanism. Kidney Int., 67, 867-874.
16. Lopez-Huertas, E. (2012) The effect of EPA and DHA on metabolic syndrome patients: a systematic review of randomised controlled trials. Br. J. Nutr., 107, S185-194.
17. Majkova, Z., Layne, J., Sunkara, M., Morris, A.J., Toborek, M. & Hennig, B. (2011) Omega-3 fatty acid oxidation products prevent vascular endothelial cell activation by coplanar polychlorinated biphenyls. Toxicol. Appl. Pharmacol., 251, 41-49.
18. Malekshahi Moghadam, A., Saedisomeolia, A., Djalali, M., Djazayery, A., Pooya, S. & Sojoudi, F. (2012) Efficacy of omega-3 fatty acid supplementation on serum levels of tumour necrosis factor-alpha, C-reactive protein and interleukin-2 in type 2 diabetes mellitus patients. Singapore Med. J., 53, 615-619.
19. Massaro, M., Scoditti, E., Carluccio, M.A. & De Caterina, R. (2008) Basic mechanisms behind the effects of n-3 fatty acids on cardiovascular disease. Prostaglandins Leukot. Essent. Fatty Acids, 79, 109-115.
20. Mickleborough, T.D., Tecklenburg, S.L., Montgomery, G.S. & Lindley, M.R. (2009) Eicosapentaenoic acid is more effective than docosahexaenoic acid in inhibiting proinflammatory mediator production and transcription from LPS-induced human asthmatic alveolar macrophage cells. Clin. Nutr., 28, 71-77.
21. Mohammadi, E., Rafraf, M., Farzadi, L., Asghari-Jafarabadi, M. & Sabour, S. (2012) Effects of omega-3 fatty acids supplementation on serum adiponectin levels and some metabolic risk factors in women with polycystic ovary syndrome. Asia Pac. J. Clin. Nutr., 21, 511-518.
22. Mozaffarian, D. & Wu, J.H. (2012) (n-3) fatty acids and cardiovascular health: are effects of EPA and DHA shared or complementary? J. Nutr., 142, 614S-625S.
23. Mullen, A., Loscher, C.E. & Roche, H.M. (2010) Anti-inflammatory effects of EPA and DHA are dependent upon time and dose-response elements associated with LPS stimulation in THP-1-derived macrophages. J. Nutr. Biochem., 21, 444-450.
24. Nakamura, N., Hamazaki, T., Kobayashi, M., Ohta, M. & Okuda, K. (1998) Effects of eicosapentaenoic acids on remnant-like particles, cholesterol concentrations and plasma fatty acid composition in patients with diabetes mellitus. In Vivo, 12, 311-314.
25. Park, J.H., Hong, K.S., Lee, E.J., Lee, J. & Kim, D.E. (2011) High levels of apolipoprotein B/AI ratio are associated with intracranial atherosclerotic stenosis. Stroke, 42, 3040-3046.
26. Parkinson, A.J., Cruz, A.L., Heyward, W.L., Bulkow, L.R., Hall, D., Barstaed, L. & Connor, W.E. (1994) Elevated concentrations of plasma omega-3 polyunsaturated fatty acids among Alaskan Eskimos. Am. J. Clin. Nutr., 59, 384-388.
27. Rupp, H., Rupp, T.P., Wagner, D., Alter, P. & Maisch, B. (2006) Microdetermination of fatty acids by gas chromatography and cardiovascular risk stratification by the "EPA+DHA level". Herz., 31, 30-49.
28. Rupp, H., Wagner, D., Rupp, T., Schulte, L.M. & Maisch, B. (2004) Risk stratification by the "EPA+DHA level" and the "EPA/AA ratio" focus on anti-inflammatory and antiarrhythmogenic effects of long-chain omega-3 fatty acids. Herz., 29, 673-685.
29. Sako, T., Mori, A., Lee, P., Goto, H., Fukuta, H., Oda, H., Saeki, K., Miki, Y., Makino, Y., Ishioka, K., Mizutani, H., Kojima, Y., Koikeda, S. & Arai, T. (2010) Supplementing transglucosidase with a high-fiber diet for prevention of postprandial hyperglycemia in streptozotocin-induced diabetic dogs. Vet. Res. Commun., 34, 161-172.
30. Sasongko, M.B., Wong, T.Y., Nguyen, T.T., Kawasaki, R., Jenkins, A., Shaw, J. & Wang, J.J. (2011) Serum apolipoprotein AI and B are stronger biomarkers of diabetic retinopathy than traditional lipids. Diabetes Care, 34, 474-479.
31. Senmaru, T., Fukui, M., Kobayashi, K., Iwase, H., Inada, S., Okada, H., Asano, M., Yamazaki, M., Hasegawa, G., Nakamura, N., Iwasaki, M., Yabe, D., Kurose, T. & Seino, Y. (2012) Dipeptidyl-peptidase IV inhibitor is effective in patients with type 2 diabetes with high serum eicosapentaenoic acid concentrations. J. Diabetes Invest., 3, 498-502.
32. Sierra-Johnson, J., Romero-Corral, A., Somers, V.K., Lopez- Jimenez, F., Walldius, G., Hamsten, A., Hellénius, M.L. & Fisher, R.M. (2007) ApoB/apoA-I ratio: an independent predictor of insulin resistance in US non-diabetic subjects. Eur. Heart J., 28, 2637-2643.
33. Takaki, A., Umemoto, S., Ono, K., Seki, K., Ryoke, T., Fujii, A., Itagaki, T., Harada, M., Tanaka, M., Yonezawa, T., Ogawa, H. & Matsuzaki, M.; ELIA study group. (2011) Add-on therapy of EPA reduces oxidative stress and inhibits the progression of aortic stiffness in patients with coronary artery disease and statin therapy: a randomized controlled study. J. Atheroscler. Thromb., 18, 857-866.
34. Thompson, A. & Danesh, J. (2006) Associations between apolipoprotein B, apolipoprotein AI, the apolipoprotein B/AI ratio and coronary heart disease: a literature-based meta-analysis of prospective studies. J. Intern. Med., 259, 481-492.
35. Wallström, P., Sonestedt, E., Hlebowicz, J., Ericson, U., Drake, I., Persson, M., Gullberg, B., Hedblad, B. & Wirfält, E. (2012) Dietary fiber and saturated fat intake associations with cardiovascular disease differ by sex in the Malmö Diet and Cancer Cohort: a prospective study. PLoS One, 7, e31637.
36. Wang, H., Khor, T.O., Saw, C.L., Lin, W., Wu, T., Huang, Y. & Kong, A.N. (2010) Role of Nrf2 in suppressing LPS-induced inflammation in mouse peritoneal macrophages by polyunsaturated fatty acids docosahexaenoic acid and eicosapentaenoic acid. Mol. Pharm., 7, 2185-2193.
37. Weldon, S.M., Mullen, A.C., Loscher, C.E., Hurley, L.A. & Roche, H.M. (2007) Docosahexaenoic acid induces an anti-inflammatory profile in lipopolysaccharide-stimulated human THP-1 macrophages more effectively than eicosapentaenoic acid. J. Nutr. Biochem., 18, 250-258.